Cargando…

Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer

The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor...

Descripción completa

Detalles Bibliográficos
Autores principales: Launonen, I.-M., Lyytikäinen, N., Casado, J., Anttila, E. A., Szabó, A., Haltia, U.-M., Jacobson, C. A., Lin, J. R., Maliga, Z., Howitt, B. E., Strickland, K. C., Santagata, S., Elias, K., D’Andrea, A. D., Konstantinopoulos, P. A., Sorger, P. K., Färkkilä, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837628/
https://www.ncbi.nlm.nih.gov/pubmed/35149709
http://dx.doi.org/10.1038/s41467-022-28389-3
_version_ 1784649956147068928
author Launonen, I.-M.
Lyytikäinen, N.
Casado, J.
Anttila, E. A.
Szabó, A.
Haltia, U.-M.
Jacobson, C. A.
Lin, J. R.
Maliga, Z.
Howitt, B. E.
Strickland, K. C.
Santagata, S.
Elias, K.
D’Andrea, A. D.
Konstantinopoulos, P. A.
Sorger, P. K.
Färkkilä, A.
author_facet Launonen, I.-M.
Lyytikäinen, N.
Casado, J.
Anttila, E. A.
Szabó, A.
Haltia, U.-M.
Jacobson, C. A.
Lin, J. R.
Maliga, Z.
Howitt, B. E.
Strickland, K. C.
Santagata, S.
Elias, K.
D’Andrea, A. D.
Konstantinopoulos, P. A.
Sorger, P. K.
Färkkilä, A.
author_sort Launonen, I.-M.
collection PubMed
description The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.
format Online
Article
Text
id pubmed-8837628
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-88376282022-03-04 Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer Launonen, I.-M. Lyytikäinen, N. Casado, J. Anttila, E. A. Szabó, A. Haltia, U.-M. Jacobson, C. A. Lin, J. R. Maliga, Z. Howitt, B. E. Strickland, K. C. Santagata, S. Elias, K. D’Andrea, A. D. Konstantinopoulos, P. A. Sorger, P. K. Färkkilä, A. Nat Commun Article The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC. Nature Publishing Group UK 2022-02-11 /pmc/articles/PMC8837628/ /pubmed/35149709 http://dx.doi.org/10.1038/s41467-022-28389-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Launonen, I.-M.
Lyytikäinen, N.
Casado, J.
Anttila, E. A.
Szabó, A.
Haltia, U.-M.
Jacobson, C. A.
Lin, J. R.
Maliga, Z.
Howitt, B. E.
Strickland, K. C.
Santagata, S.
Elias, K.
D’Andrea, A. D.
Konstantinopoulos, P. A.
Sorger, P. K.
Färkkilä, A.
Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
title Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
title_full Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
title_fullStr Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
title_full_unstemmed Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
title_short Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer
title_sort single-cell tumor-immune microenvironment of brca1/2 mutated high-grade serous ovarian cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837628/
https://www.ncbi.nlm.nih.gov/pubmed/35149709
http://dx.doi.org/10.1038/s41467-022-28389-3
work_keys_str_mv AT launonenim singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT lyytikainenn singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT casadoj singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT anttilaea singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT szaboa singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT haltiaum singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT jacobsonca singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT linjr singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT maligaz singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT howittbe singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT stricklandkc singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT santagatas singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT eliask singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT dandreaad singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT konstantinopoulospa singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT sorgerpk singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer
AT farkkilaa singlecelltumorimmunemicroenvironmentofbrca12mutatedhighgradeserousovariancancer